Human Papillomavirus-Related Malignant Neoplasm

Human Papillomavirus-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

168 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 37
Ph III recruiting: 2
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07565740	Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC	recruiting	Phase 1	9	West China HospitalOTHER	1	Sep 22, 2026	clinicaltrials
NCT05985681	Testing RG1-VLP Vaccine to Prevent HPV-related Cancers	recruiting	Phase 1	18	National Cancer Institute (NCI)NIH	1	Sep 9, 2026	clinicaltrials
NCT06016920